Cargando…
HDAC2‐dependent miRNA signature in acute myeloid leukemia
Acute myeloid leukemia (AML) arises from a complex sequence of biological and finely orchestrated events that are still poorly understood. Increasingly, epigenetic studies are providing exciting findings that may be exploited in promising and personalized cutting‐edge therapies. A more appropriate a...
Autores principales: | Conte, Mariarosaria, Dell'Aversana, Carmela, Sgueglia, Giulia, Carissimo, Annamaria, Altucci, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790563/ https://www.ncbi.nlm.nih.gov/pubmed/31254352 http://dx.doi.org/10.1002/1873-3468.13521 |
Ejemplares similares
-
miRNA-mediated deregulation in leukemia
por: Dell’Aversana, Carmela, et al.
Publicado: (2012) -
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape
por: Conte, Mariarosaria, et al.
Publicado: (2014) -
Hypoxia-Regulated miRNAs in Human Mesenchymal Stem Cells: Exploring the Regulatory Effects in Ischemic Disorders
por: Dell’Aversana, Carmela, et al.
Publicado: (2019) -
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
por: Lepore, Ilaria, et al.
Publicado: (2013) -
Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies
por: Massaro, Crescenzo, et al.
Publicado: (2020)